This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 734318 Submitted by lobbyist on: February 5, 2018 04:24:25 PM Accepted by Registrar on: February 6, 2018 12:22:51 PM
Designated Filer Information
Squires, Geoffrey
22093-46B Avenue
Langley, BC, V2Z 1A9
604-218-9838
Canada
Organization Information
Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative health care products and medicines to improve the well-being of Canadians. Novartis is a leading investor in pharmaceutical research and development worldwide and in Canada.
Novartis Pharmaceuticals Canada Inc. employs more than 600 people in Canada. It has been named multiple times as one of the "50 Best Employers in Canada". For further information, please visit www.novartis.ca.
385 Boul Bouchard
Dorval, BC, H9S 1N9
514-631-6775
Canada
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
February 5, 2018
August 5, 2018
Organization's In-House Lobbyists
Name:
Brown, Charles
February 5, 2018
Inactivation Date:
August 10, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Facilitate patient access to Novartis medicines through listings by Pharmacare and the BC Cancer Agency. Enter into product listing agreements reflecting negotiations completed with the Pan Canadian Pharmaceutical Alliance. Facilitate patient access to Novartis medicines within provincial health authorities.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
Health
February 5, 2018
Public Agency
Provincial Health Services Authority
February 5, 2018
Name:
McLean, Michael
February 5, 2018
Inactivation Date:
August 10, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Facilitate patient access to Novartis medicines through listings by Pharmacare and the BC Cancer Agency. Enter into product listing agreements reflecting negotiations completed with the Pan Canadian Pharmaceutical Alliance. Facilitate patient access to Novartis medicines within provincial health authorities. discuss Novartis Pharmaceuticals presence in Canada & British Columbia and contribution to the health system
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Minister
Ralston,
Bruce
Minister of Jobs, Trade and Technology
June 25, 2018
Staff of Minister
Winter,
Alan
Minister of Jobs, Trade and Technology
June 25, 2018
Public Agency
Health
February 5, 2018
Public Agency
Provincial Health Services Authority
February 5, 2018
Name:
Murray, Janice
June 25, 2018
Inactivation Date:
August 10, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
discuss Novartis Pharmaceuticals presence in Canada & British Columbia and contribution to the health system
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Minister
Ralston,
Bruce
Minister of Jobs, Trade and Technology
June 25, 2018
Staff of Minister
Winter,
Alan
Minister of Jobs, Trade and Technology
June 25, 2018
Name:
Prevost, Lison
June 25, 2018
Inactivation Date:
August 10, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
discuss Novartis Pharmaceuticals presence in Canada & British Columbia and contribution to the health system
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Minister
Ralston,
Bruce
Minister of Jobs, Trade and Technology
June 25, 2018
Staff of Minister
Winter,
Alan
Minister of Jobs, Trade and Technology
June 25, 2018
Name:
Squires, Geoffrey
February 5, 2018
Inactivation Date:
August 10, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Facilitate patient access to Novartis medicines through listings by Pharmacare and the BC Cancer Agency. Enter into product listing agreements reflecting negotiations completed with the Pan Canadian Pharmaceutical Alliance. Facilitate patient access to Novartis medicines within provincial health authorities. discuss Novartis Pharmaceuticals presence in Canada & British Columbia and contribution to the health system
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Staff of Minister
Jethani,
Salima
Minister of Jobs, Trade and Technology
June 25, 2018
Minister
Ralston,
Bruce
Minister of Jobs, Trade and Technology
June 25, 2018
Staff of Minister
Winter,
Alan
Minister of Jobs, Trade and Technology
June 25, 2018
Public Agency
Health
February 5, 2018
Public Agency
Provincial Health Services Authority
February 5, 2018
Name:
Trifonopoulos, Helen
February 5, 2018
Inactivation Date:
August 10, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Facilitate patient access to Novartis medicines through listings by Pharmacare and the BC Cancer Agency. Enter into product listing agreements reflecting negotiations completed with the Pan Canadian Pharmaceutical Alliance. Facilitate patient access to Novartis medicines within provincial health authorities.
